Bressler B, Yarur A, Silverberg MS, Bassel M, et al. Vedolizumab and Anti-TNFalpha Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. J Crohns Colitis 2021 Mar 31. pii: 6205394. doi: 10.1093.
PMID: 33786600